Literature DB >> 15170393

Recurrent pregnancy loss and its relation to FV Leiden, FII G20210A and polymorphisms of plasminogen activator and plasminogen activator inhibitor.

Cornelia E Wolf1, Hannelore Haubelt, Hans Ulrich Pauer, Bernd Hinney, Claudette Krome-Cesar, Tobias J Legler, Peter Hellstern, Günter Emons, Barbara Zoll, Michael Köhler.   

Abstract

Thrombophilic disorders and hypofibrinolysis were demonstrated to be risk factors in a majority of women with recurrent pregnancy loss (RPL) and infertility. We investigated the association of FV G1691A mutation, F II G20210A gene polymorphism (PM), 4G/5G PAI-1 and Alu I/D tPA PM in 32 women with infertility and 49 women with at least 2 unexplained early abortions. FV Leiden mutation was significantly more common in women with RPL (10%, p = 0.02) and infertility (19%, p = 0.0005) compared with controls (2%). PAI-1 4G PM and t-PA Alu I PM, alone or in combination, were not associated with RPL or infertility. 9/49 women with RPL showed coagulation disorders with heterozygous FV Leiden mutation (5), FXII (1), protein C (1) or protein S (2) deficiency. However, due to the small number of patients studied, no definite conclusion can be drawn. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15170393     DOI: 10.1159/000077821

Source DB:  PubMed          Journal:  Pathophysiol Haemost Thromb        ISSN: 1424-8832


  7 in total

1.  Association of Prothrombin (A20210G) and Factor V Leiden (A506G) with Recurrent Pregnancy Loss.

Authors:  Dana Mierla; Camelia Szmal; Daniela Neagos; Ruxandra Cretu; Veronica Stoian; Dumitru Jardan
Journal:  Maedica (Buchar)       Date:  2012-09

2.  Association between plasminogen activator inhibitor 1 gene mutation and different subgroups of recurrent miscarriage and implantation failure.

Authors:  Farhad Khosravi; Saeed Zarei; Negah Ahmadvand; Zahra Akbarzadeh-Pasha; Elham Savadi; Amir-Hassan Zarnani; Mohammad-Reza Sadeghi; Mahmood Jeddi-Tehrani
Journal:  J Assist Reprod Genet       Date:  2013-11-06       Impact factor: 3.412

3.  Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.

Authors:  Xuejiao Li; Yukun Liu; Rui Zhang; Jianping Tan; Libin Chen; Yinglin Liu
Journal:  Med Sci Monit       Date:  2015-04-11

4.  Association Between - 675 ID, 4G/5G PAI-1 Gene Polymorphism and Pregnancy Loss: A Systematic Review.

Authors:  Grazyna Adler; Emir Mahmutbegovic; Amina Valjevac; Mateusz A Adler; Nevena Mahmutbegovic; Krzysztof Safranow; Ewa Czerska; Anna Pawinska-Matecka; Iwona Ciechanowicz; Damir Marjanovic
Journal:  Acta Inform Med       Date:  2018-10

5.  Association of plasminogen activator inhibitor-1 and angiotensin converting enzyme polymorphisms with recurrent pregnancy loss in Iranian women.

Authors:  Fatemeh Shakarami; Mohammad Taghi Akbari; Shohreh Zare Karizi
Journal:  Iran J Reprod Med       Date:  2015-10

6.  Increased Circulating Levels of Tissue-Type Plasminogen Activator Are Associated with the Risk of Spontaneous Abortion During the First Trimester of Pregnancy.

Authors:  Lara J Monteiro; Manuel Varas-Godoy; Stephanie Acuña-Gallardo; Paula Correa; Gianluca Passalacqua; Max Monckeberg; Gregory E Rice; Sebastián E Illanes
Journal:  Diagnostics (Basel)       Date:  2020-04-01

7.  Association of Polymorphisms in Plasminogen Activator Inhibitor-1 (PAI-1), Tissue Plasminogen Activator (tPA), and Renin (REN) with Recurrent Pregnancy Loss in Korean Women.

Authors:  Hee Young Cho; Han Sung Park; Eun Hee Ahn; Eun Ju Ko; Hyeon Woo Park; Young Ran Kim; Ji Hyang Kim; Woo Sik Lee; Nam Keun Kim
Journal:  J Pers Med       Date:  2021-12-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.